The combination of medical, scientific, regulatory and technical expertise has made Cardiabase a global leader in the field, with a contribution to more than 500 studies in over 50 countries and 7500 clinical sites.
Relying on their extensive combined experience in cardiovascular safety assessment during drug development, Drs Voiriot and Wicker offer a full range of consulting services to help you design the most time and cost-efficient cardiovascular safety assessment program.
Services include assessment strategy fully integrated with your clinical development plan, protocol design, analysis and interpretation, interaction with regulatory agencies and phase I clinics in Europe and North America.
Our multidisciplinary team of professionals has always been committed to offering innovative, compliant, site-friendly and cost-effective solutions:
Cardiabase has ongoing research and development activities in ECG Analysis Systems.

Cardiabase has developed a common ECG format and is able to process most digital ECG data formats.